Featured News
611Wire StoriesGraphene & Solar Technologies New Shareholder Letter & Update
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company Update. Acquisition of high-tech “Thin-Film” nanotech development...
- 677Wire Stories
Graphene & Solar Technologies New Shareholder Letter & Update
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company Update. Acquisition of high-tech “Thin-Film” nanotech development...
- 653Wire Stories
Otsuka Medical Devices’ REQUIRE Trial Results Presented at Japan Society of Hypertension Annual Meeting
REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of Hypertension (JSH) 43rd Annual Meeting PALO ALTO,...
- 749Wire Stories
Otsuka Medical Devices’ REQUIRE Trial Results Presented at Japan Society of Hypertension Annual Meeting
REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of Hypertension (JSH) 43rd Annual Meeting PALO ALTO,...
- 602Wire Stories
Graphene & Solar Technologies New Shareholder Letter & Update
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company Update. Acquisition of high-tech “Thin-Film” nanotech development...
- 786Wire Stories
Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company
Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class agents and proprietary platforms Initial TCRyption programs...
- 661Wire Stories
Otsuka Medical Devices’ REQUIRE Trial Results Presented at Japan Society of Hypertension Annual Meeting
REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of Hypertension (JSH) 43rd Annual Meeting PALO ALTO,...
- 611Wire Stories
Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company
Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class agents and proprietary platforms Initial TCRyption programs...
- 723Wire Stories
Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company
Combination brings an additional therapeutic modality into Treadwell’s growing pre-clinical pipeline of first in class agents and proprietary platforms Initial TCRyption programs...
- 586Wire Stories
MojitoSwap DEX Launched on KCC With 1,000,000 MJT Airdrops to Reward the KuCoin and KCS Community
HONG KONG–(BUSINESS WIRE)–#BTC–MojitoSwap, a KCC-based decentralized exchange (DEX) has officially launched. Users can start trading on MojitoSwap from October 15, 2021. MojitoSwap...
- 545Wire Stories
MojitoSwap DEX Launched on KCC With 1,000,000 MJT Airdrops to Reward the KuCoin and KCS Community
HONG KONG–(BUSINESS WIRE)–#BTC–MojitoSwap, a KCC-based decentralized exchange (DEX) has officially launched. Users can start trading on MojitoSwap from October 15, 2021. MojitoSwap...
